Introduction Semaglutide has rapidly gained recognition as a groundbreaking medication, revolutionizing how we approach chronic health conditions like obesity and type 2 diabetes. A member of the GLP-1 receptor agonist family, Semaglutide mimics the body’s natural glucagon-like peptide-1 (GLP-1) hormone, playing a critical role in blood sugar regulation, insulin secretion, https://limawebdirectory.com/listings536184/semaglutide-a-breakthrough-in-managing-diabetes-obesity-and-cardiovascular-health